Heart attack patients may ditch aspirin sooner with new drug cocktail

NCT ID NCT06543082

Recruiting now Disease control Sponsor: CHA University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if taking colchicine (an anti-inflammatory drug) along with a single blood thinner (ticagrelor) right after a heart attack stent is safe and works well. About 490 adults who had a heart attack and received a specific type of stent will participate. The goal is to see if this approach reduces heart-related problems and bleeding risks compared to standard longer-term dual therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME

Contacts and locations

Locations

CHA Bundang Medical Center
RECRUITING

Seongnam-si, Gyeonggi-do, 13496, South Korea
Ewha Womans University Seoul Hospital
RECRUITING

Seoul, South Korea
Gangnam Severance Hospital
RECRUITING

Seoul, South Korea
Keimyung University Dongsan Hospital
RECRUITING

Daegu, South Korea
Myongji Hospital
RECRUITING

Ilsan, South Korea
National Health Insurance Service Ilsan Hospital
RECRUITING

Ilsan, South Korea
Seoul National University Bundang Hospital
RECRUITING

Seongnam, South Korea
Wonju Severance Christian Hospital
RECRUITING

Wŏnju, South Korea
Wonkwang University Hospital
RECRUITING

Iksan, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.